Jessica Hagen

The acquisition allows Cerebral to offer ADHD patients ongoing support through therapy, skill-building modules, medication management and community engagement.

The hybrid doula-focused care platform will use the seed funding to scale nationwide.

The Series B marks the company's third funding round in less than a year.

The new alliance adds to b.well's partnerships with OpenAI, Google and Samsung to unify and personalize AI-driven health answers using individuals' medical data.

The company will use the funds to enhance its platform, grow its workforce and expand partnerships with health systems to automate medication approval workflows.

The company will use the funds to accelerate development of its AI precision health platform.

The company acquired Intelerad for $2.3 billion in cash and debt financing and expects around $270 million in recurring annual revenue and a high-single-digit return on investment within five years.

​The company will use the funds to scale its platform, hire engineers and data scientists, deepen clinical integrations and speed the deployment of custom AI agents.

The company's lab allows AI systems to create, evaluate and deploy new machine learning models with minimal human intervention.

The tech giant introduced new AI-enabled healthcare updates to Search and Fitbit, including expanded tools to help patients collect and share information.